ERD

miR-122-regulated metabolic circuits: micro-management of lipid metabolism in the human liver

Project: HEP-CAR

Updated at: 29-04-2024

Show more information

Project acronym HEP-CAR

ANTI-CLAUDIN 1 ANTIBODIES FOR USE IN THE TREATMENT OF COLORECTAL CANCER

Project: HEP-CAR

Updated at: 29-04-2024

Show more information

Project acronym HEP-CAR

Perspectives and limitations for nucleo(t)side analogs in future HBV therapies

Project: HEP-CAR

Updated at: 29-04-2024

Show more information

Project acronym HEP-CAR

Mechanisms of HBV-induced hepatocellular carcinoma

Project: HEP-CAR

Updated at: 29-04-2024

Show more information

Project acronym HEP-CAR

Hepatitis B protein HBx binds the DLEU2 lncRNA to sustain cccDNA and host cancer-related gene transcription

Project: HEP-CAR

Updated at: 29-04-2024

Show more information

Project acronym HEP-CAR

Hepatitis Delta Virus histone mimicry drives the recruitment of chromatin remodelers for viral RNA replication

Project: HEP-CAR

Updated at: 29-04-2024

Show more information

Project acronym HEP-CAR

Non-Coding RNAs and Hepatitis C Virus-Induced Hepatocellular Carcinoma

Project: HEP-CAR

Updated at: 29-04-2024

Show more information

Project acronym HEP-CAR

The histone deacetylase inhibiting drug Entinostat induces lipid accumulation in differentiated HepaRG cells

Project: HEP-CAR

Updated at: 29-04-2024

Show more information

Project acronym HEP-CAR

Challenges to a Cure for HBV Infection

Project: HEP-CAR

Updated at: 29-04-2024

Show more information

Project acronym HEP-CAR

Solute Carrier NTCP Regulates Innate Antiviral Immune Responses Targeting Hepatitis C Virus Infection of Hepatocytes

Project: HEP-CAR

Updated at: 29-04-2024

Show more information

Project acronym HEP-CAR

miR-135a-5p-mediated downregulation of protein tyrosine phosphatase receptor delta is a candidate driver of HCV-associat...

Project: HEP-CAR

Updated at: 29-04-2024

Show more information

Project acronym HEP-CAR

Multimodal imaging of a humanized orthotopic model of hepatocellular carcinoma in immunodeficient mice

Project: HEP-CAR

Updated at: 29-04-2024

Show more information

Project acronym HEP-CAR

Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis

Project: HEP-CAR

Updated at: 29-04-2024

Show more information

Project acronym HEP-CAR

Imaging-based surrogate markers of transcriptome subclasses and signatures in hepatocellular carcinoma: preliminary resu...

Project: HEP-CAR

Updated at: 29-04-2024

Show more information

Project acronym HEP-CAR

Viral hepatitis and liver cancer

Project: HEP-CAR

Updated at: 29-04-2024

Show more information

Project acronym HEP-CAR

Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity

Project: HEP-CAR

Updated at: 29-04-2024

Show more information

Project acronym HEP-CAR

IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Expe...

Project: HEP-CAR

Updated at: 29-04-2024

Show more information

Project acronym HEP-CAR

Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma

Project: HEP-CAR

Updated at: 29-04-2024

Show more information

Project acronym HEP-CAR

Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features

Project: HEP-CAR

Updated at: 29-04-2024

Show more information

Project acronym HEP-CAR

Molecular Pathogenesis and Targeted Therapies for Intrahepatic Cholangiocarcinoma

Project: HEP-CAR

Updated at: 29-04-2024

Show more information

Project acronym HEP-CAR

Advancing hepatitis B virus entry inhibitors

Project: HEP-CAR

Updated at: 29-04-2024

Show more information

Project acronym HEP-CAR

Plasmodium P36 determines host cell receptor usage during sporozoite invasion

Project: HEP-CAR

Updated at: 29-04-2024

Show more information

Project acronym HEP-CAR

Hepatocellular carcinoma

Project: HEP-CAR

Updated at: 29-04-2024

Show more information

Project acronym HEP-CAR

Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular ...

Project: HEP-CAR

Updated at: 29-04-2024

Show more information

Project acronym HEP-CAR

Autotaxin-lysophosphatidic acid receptor signalling regulates hepatitis C virus replication

Project: HEP-CAR

Updated at: 29-04-2024

Show more information

Project acronym HEP-CAR

The Measles Virus Receptor SLAMF1 Can Mediate Particle Endocytosis

Project: HEP-CAR

Updated at: 29-04-2024

Show more information

Project acronym HEP-CAR

SMAD About Hepatitis C Virus Cell Entry and Liver Disease

Project: HEP-CAR

Updated at: 29-04-2024

Show more information

Project acronym HEP-CAR

Multifaceted role of E-cadherin in hepatitis C virus infection and pathogenesis

Project: HEP-CAR

Updated at: 29-04-2024

Show more information

Project acronym HEP-CAR

Objective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCC

Project: HEP-CAR

Updated at: 29-04-2024

Show more information

Project acronym HEP-CAR

Tracking HCV protease population diversity during transmission and susceptibility of founder populations to antiviral th...

Project: HEP-CAR

Updated at: 29-04-2024

Show more information

Project acronym HEP-CAR

Resources

Selected filters:

miR-122-regulated metabolic circuits: micro-management of lipid metabolism in the human liver

ANTI-CLAUDIN 1 ANTIBODIES FOR USE IN THE TREATMENT OF COLORECTAL CANCER

Perspectives and limitations for nucleo(t)side analogs in future HBV therapies

Mechanisms of HBV-induced hepatocellular carcinoma

Hepatitis B protein HBx binds the DLEU2 lncRNA to sustain cccDNA and host cancer-related gene transcription

Hepatitis Delta Virus histone mimicry drives the recruitment of chromatin remodelers for viral RNA replication

Non-Coding RNAs and Hepatitis C Virus-Induced Hepatocellular Carcinoma

The histone deacetylase inhibiting drug Entinostat induces lipid accumulation in differentiated HepaRG cells

Challenges to a Cure for HBV Infection

Solute Carrier NTCP Regulates Innate Antiviral Immune Responses Targeting Hepatitis C Virus Infection of Hepatocytes

miR-135a-5p-mediated downregulation of protein tyrosine phosphatase receptor delta is a candidate driver of HCV-associat...

Multimodal imaging of a humanized orthotopic model of hepatocellular carcinoma in immunodeficient mice

Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis

Imaging-based surrogate markers of transcriptome subclasses and signatures in hepatocellular carcinoma: preliminary resu...

Viral hepatitis and liver cancer

Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity

IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Expe...

Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma

Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features

Molecular Pathogenesis and Targeted Therapies for Intrahepatic Cholangiocarcinoma

Advancing hepatitis B virus entry inhibitors

Plasmodium P36 determines host cell receptor usage during sporozoite invasion

Hepatocellular carcinoma

Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular ...

Autotaxin-lysophosphatidic acid receptor signalling regulates hepatitis C virus replication

The Measles Virus Receptor SLAMF1 Can Mediate Particle Endocytosis

SMAD About Hepatitis C Virus Cell Entry and Liver Disease

Multifaceted role of E-cadherin in hepatitis C virus infection and pathogenesis

Objective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCC

Tracking HCV protease population diversity during transmission and susceptibility of founder populations to antiviral th...